Literature DB >> 24583476

MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a.

Min Min1, Lihua Peng, Yunsheng Yang, Mingzhou Guo, Weifeng Wang, Gang Sun.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) are important posttranscriptional regulators of gene expression. The precise role of miRNAs in ulcerative colitis (UC) is not completely understood. The purpose of this study was to identify miRNAs that are induced in patients with active UC and to assess the effect of miR-155 on improving intestinal inflammation.
METHODS: The miRNA profiles in patients with active UC (n = 20) and healthy subjects (n = 16) were examined using miRNA microarrays. miR-155 upregulation was confirmed by quantitative RT-PCR. Regulation of the target gene FOXO3a expression by miR-155 was assessed using luciferase reporter construct assays and miR-155 mimic or inhibitor transfections. The effects of FOXO3a or miR-155 on IκBα or IL-8 were detected by Western blot or enzyme-linked immunosorbent assay in HT29 cells, respectively.
RESULTS: We identified 68 miRNAs that were differentially expressed (33 upregulated and 35 downregulated) in patients with active UC compared with healthy controls. One of the upregulated miRNAs in the UC tissue was miR-155 (1.22-fold, P < 0.03), which plays a key role in the regulation of inflammatory pathways. In patients with active UC, miR-155 was significantly upregulated, and the expression of FOXO3a dramatically decreased. Luciferase reporter assays demonstrated that miR-155 directly targets FOXO3a and affects the protein expression of FOXO3a in HT29 cells. Moreover, silenced FOXO3a and the overexpression of miR-155 increased the levels of IL-8 in TNF-α-treated HT29 cells by suppressing the inhibitory IκBα.
CONCLUSIONS: miR-155 appears to play a role in the intestinal inflammation of patients with active UC by downregulating the expression of FOXO3a. This process may activate the nuclear factor kappa B signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24583476     DOI: 10.1097/MIB.0000000000000009

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  40 in total

1.  Dietary apigenin reduces LPS-induced expression of miR-155 restoring immune balance during inflammation.

Authors:  Daniel Arango; Mayra Diosa-Toro; Laura S Rojas-Hernandez; Jessica L Cooperstone; Steven J Schwartz; Xiaokui Mo; Jinmai Jiang; Thomas D Schmittgen; Andrea I Doseff
Journal:  Mol Nutr Food Res       Date:  2015-02-23       Impact factor: 5.914

2.  Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.

Authors:  Lianhua Yan; Fen Hu; Xiaofei Yan; Yuzhen Wei; Wenhan Ma; Ya Wang; Shuai Lu; Zhaohui Wang
Journal:  J Mol Med (Berl)       Date:  2016-04-06       Impact factor: 4.599

Review 3.  Role of MiRNAs in Inflammatory Bowel Disease.

Authors:  Bo Cao; Xin Zhou; Jiaojiao Ma; Wei Zhou; Wanli Yang; Daiming Fan; Liu Hong
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

Review 4.  Posttranscriptional regulation of FOXO expression: microRNAs and beyond.

Authors:  P Urbánek; L-O Klotz
Journal:  Br J Pharmacol       Date:  2016-05-02       Impact factor: 8.739

Review 5.  Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.

Authors:  Artin Soroosh; Marina Koutsioumpa; Charalabos Pothoulakis; Dimitrios Iliopoulos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-11-16       Impact factor: 4.052

6.  Blunting Autoantigen-induced FOXO3a Protein Phosphorylation and Degradation Is a Novel Pathway of Glucocorticoids for the Treatment of Systemic Lupus Erythematosus.

Authors:  Mudan Lu; Wei Xu; Bo Gao; Sidong Xiong
Journal:  J Biol Chem       Date:  2016-08-01       Impact factor: 5.157

7.  Integrated analysis of circRNAs and mRNAs expression profile revealed the involvement of hsa_circ_0007919 in the pathogenesis of ulcerative colitis.

Authors:  Tingting Wang; Ning Chen; Weixia Ren; Fangfang Liu; Fangfang Gao; Lei Ye; Ying Han; Yujun Zhang; Yulan Liu
Journal:  J Gastroenterol       Date:  2019-04-29       Impact factor: 7.527

Review 8.  MicroRNAs in mucosal inflammation.

Authors:  Viola Neudecker; Xiaoyi Yuan; Jessica L Bowser; Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2017-07-20       Impact factor: 4.599

9.  Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.

Authors:  Dániel Szűcs; Nóra Judit Béres; Réka Rokonay; Kriszta Boros; Katalin Borka; Zoltán Kiss; András Arató; Attila J Szabó; Ádám Vannay; Erna Sziksz; Csaba Bereczki; Gábor Veres
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

Review 10.  MicroRNAs: how many in inflammatory bowel disease?

Authors:  Jeremy S Schaefer
Journal:  Curr Opin Gastroenterol       Date:  2016-07       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.